nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.136	0.365	CbGbCtD
Mirtazapine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0945	0.255	CbGbCtD
Mirtazapine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0864	0.233	CbGbCtD
Mirtazapine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.055	0.148	CbGbCtD
Mirtazapine—Salivary gland enlargement—Cyclosporine—focal segmental glomerulosclerosis	0.016	0.0346	CcSEcCtD
Mirtazapine—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0124	0.0269	CcSEcCtD
Mirtazapine—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00947	0.0205	CcSEcCtD
Mirtazapine—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00919	0.0199	CcSEcCtD
Mirtazapine—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00906	0.0196	CcSEcCtD
Mirtazapine—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00783	0.0169	CcSEcCtD
Mirtazapine—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00783	0.0169	CcSEcCtD
Mirtazapine—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00774	0.0167	CcSEcCtD
Mirtazapine—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00756	0.0163	CcSEcCtD
Mirtazapine—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.0073	0.0158	CcSEcCtD
Mirtazapine—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.0073	0.0158	CcSEcCtD
Mirtazapine—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00678	0.0147	CcSEcCtD
Mirtazapine—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00616	0.0133	CcSEcCtD
Mirtazapine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.0132	CcSEcCtD
Mirtazapine—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.0059	0.0128	CcSEcCtD
Mirtazapine—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00571	0.0123	CcSEcCtD
Mirtazapine—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00571	0.0123	CcSEcCtD
Mirtazapine—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00548	0.0119	CcSEcCtD
Mirtazapine—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00528	0.0114	CcSEcCtD
Mirtazapine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00513	0.0111	CcSEcCtD
Mirtazapine—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.011	CcSEcCtD
Mirtazapine—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.0109	CcSEcCtD
Mirtazapine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00495	0.0107	CcSEcCtD
Mirtazapine—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.0106	CcSEcCtD
Mirtazapine—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.0106	CcSEcCtD
Mirtazapine—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.0106	CcSEcCtD
Mirtazapine—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.0104	CcSEcCtD
Mirtazapine—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.0104	CcSEcCtD
Mirtazapine—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.0103	CcSEcCtD
Mirtazapine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.0096	CcSEcCtD
Mirtazapine—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.00944	CcSEcCtD
Mirtazapine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00927	CcSEcCtD
Mirtazapine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00927	CcSEcCtD
Mirtazapine—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.00917	CcSEcCtD
Mirtazapine—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.00912	CcSEcCtD
Mirtazapine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.00878	CcSEcCtD
Mirtazapine—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00868	CcSEcCtD
Mirtazapine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00833	CcSEcCtD
Mirtazapine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.00817	CcSEcCtD
Mirtazapine—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00371	0.00801	CcSEcCtD
Mirtazapine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00369	0.00798	CcSEcCtD
Mirtazapine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00794	CcSEcCtD
Mirtazapine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.00787	CcSEcCtD
Mirtazapine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00779	CcSEcCtD
Mirtazapine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00361	0.00779	CcSEcCtD
Mirtazapine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.00772	CcSEcCtD
Mirtazapine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00752	CcSEcCtD
Mirtazapine—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00742	CcSEcCtD
Mirtazapine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00729	CcSEcCtD
Mirtazapine—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.00717	CcSEcCtD
Mirtazapine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00711	CcSEcCtD
Mirtazapine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00697	CcSEcCtD
Mirtazapine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00692	CcSEcCtD
Mirtazapine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00686	CcSEcCtD
Mirtazapine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.00686	CcSEcCtD
Mirtazapine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.0066	CcSEcCtD
Mirtazapine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00639	CcSEcCtD
Mirtazapine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00617	CcSEcCtD
Mirtazapine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00615	CcSEcCtD
Mirtazapine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00607	CcSEcCtD
Mirtazapine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.00591	CcSEcCtD
Mirtazapine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00587	CcSEcCtD
Mirtazapine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.00579	CcSEcCtD
Mirtazapine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00563	CcSEcCtD
Mirtazapine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00557	CcSEcCtD
Mirtazapine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00548	CcSEcCtD
Mirtazapine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00545	CcSEcCtD
Mirtazapine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.0054	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0053	CcSEcCtD
Mirtazapine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00527	CcSEcCtD
Mirtazapine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00524	CcSEcCtD
Mirtazapine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00524	CcSEcCtD
Mirtazapine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00522	CcSEcCtD
Mirtazapine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00522	CcSEcCtD
Mirtazapine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00512	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00508	CcSEcCtD
Mirtazapine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00507	CcSEcCtD
Mirtazapine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00504	CcSEcCtD
Mirtazapine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00484	CcSEcCtD
Mirtazapine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00482	CcSEcCtD
Mirtazapine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0048	CcSEcCtD
Mirtazapine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00479	CcSEcCtD
Mirtazapine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00476	CcSEcCtD
Mirtazapine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.00473	CcSEcCtD
Mirtazapine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.0045	CcSEcCtD
Mirtazapine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00438	CcSEcCtD
Mirtazapine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00433	CcSEcCtD
Mirtazapine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00431	CcSEcCtD
Mirtazapine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00426	CcSEcCtD
Mirtazapine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00423	CcSEcCtD
Mirtazapine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.0042	CcSEcCtD
Mirtazapine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00414	CcSEcCtD
Mirtazapine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00412	CcSEcCtD
Mirtazapine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00411	CcSEcCtD
Mirtazapine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.00408	CcSEcCtD
Mirtazapine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00393	CcSEcCtD
Mirtazapine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.0039	CcSEcCtD
Mirtazapine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00388	CcSEcCtD
Mirtazapine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00386	CcSEcCtD
Mirtazapine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00379	CcSEcCtD
Mirtazapine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00377	CcSEcCtD
Mirtazapine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00376	CcSEcCtD
Mirtazapine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00366	CcSEcCtD
Mirtazapine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00364	CcSEcCtD
Mirtazapine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00362	CcSEcCtD
Mirtazapine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00357	CcSEcCtD
Mirtazapine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00357	CcSEcCtD
Mirtazapine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00357	CcSEcCtD
Mirtazapine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00356	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00355	CcSEcCtD
Mirtazapine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00353	CcSEcCtD
Mirtazapine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0035	CcSEcCtD
Mirtazapine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00345	CcSEcCtD
Mirtazapine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00343	CcSEcCtD
Mirtazapine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0034	CcSEcCtD
Mirtazapine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00336	CcSEcCtD
Mirtazapine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.00335	CcSEcCtD
Mirtazapine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00333	CcSEcCtD
Mirtazapine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00331	CcSEcCtD
Mirtazapine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00327	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00312	CcSEcCtD
Mirtazapine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0031	CcSEcCtD
Mirtazapine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00308	CcSEcCtD
Mirtazapine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00305	CcSEcCtD
Mirtazapine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00305	CcSEcCtD
Mirtazapine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00302	CcSEcCtD
Mirtazapine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00298	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00296	CcSEcCtD
Mirtazapine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00295	CcSEcCtD
Mirtazapine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00293	CcSEcCtD
Mirtazapine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00293	CcSEcCtD
Mirtazapine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00282	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0028	CcSEcCtD
Mirtazapine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00272	CcSEcCtD
Mirtazapine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00271	CcSEcCtD
Mirtazapine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00271	CcSEcCtD
Mirtazapine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00252	CcSEcCtD
Mirtazapine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00246	CcSEcCtD
Mirtazapine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00242	CcSEcCtD
Mirtazapine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00234	CcSEcCtD
Mirtazapine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00227	CcSEcCtD
Mirtazapine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00218	CcSEcCtD
Mirtazapine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000999	0.00216	CcSEcCtD
Mirtazapine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000998	0.00216	CcSEcCtD
Mirtazapine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000993	0.00215	CcSEcCtD
Mirtazapine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000942	0.00204	CcSEcCtD
Mirtazapine—ADRB1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.79e-05	0.000469	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.78e-05	0.000469	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.78e-05	0.000468	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.76e-05	0.000467	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.74e-05	0.000466	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.69e-05	0.000463	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.68e-05	0.000462	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.64e-05	0.00046	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.62e-05	0.000459	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.61e-05	0.000459	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	7.58e-05	0.000456	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.57e-05	0.000456	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.47e-05	0.00045	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.45e-05	0.000449	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.43e-05	0.000448	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.41e-05	0.000446	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.41e-05	0.000446	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.37e-05	0.000444	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.36e-05	0.000443	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.23e-05	0.000435	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	7.22e-05	0.000435	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.21e-05	0.000434	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.21e-05	0.000434	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	7.18e-05	0.000432	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.17e-05	0.000432	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.14e-05	0.00043	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	7.14e-05	0.00043	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	7.13e-05	0.000429	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.09e-05	0.000427	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	7.07e-05	0.000426	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	7.06e-05	0.000425	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	7.05e-05	0.000424	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	7.02e-05	0.000423	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.94e-05	0.000418	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.91e-05	0.000416	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.78e-05	0.000409	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.75e-05	0.000406	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.71e-05	0.000404	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.62e-05	0.000399	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.56e-05	0.000395	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.56e-05	0.000395	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.54e-05	0.000394	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.53e-05	0.000394	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.52e-05	0.000392	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.51e-05	0.000392	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.5e-05	0.000392	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.45e-05	0.000389	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.44e-05	0.000388	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.44e-05	0.000388	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	6.42e-05	0.000387	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.42e-05	0.000387	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.42e-05	0.000387	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.4e-05	0.000385	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	6.39e-05	0.000385	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.38e-05	0.000385	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.37e-05	0.000384	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	6.35e-05	0.000383	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.32e-05	0.000381	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	6.32e-05	0.000381	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.3e-05	0.00038	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.26e-05	0.000377	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	6.24e-05	0.000376	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.23e-05	0.000375	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.19e-05	0.000373	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.16e-05	0.000371	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.08e-05	0.000366	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	6.05e-05	0.000364	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.03e-05	0.000363	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.99e-05	0.000361	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.96e-05	0.000359	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.95e-05	0.000359	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.95e-05	0.000359	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.87e-05	0.000354	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.86e-05	0.000353	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.85e-05	0.000353	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.85e-05	0.000353	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.85e-05	0.000352	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.82e-05	0.000351	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.82e-05	0.000351	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.78e-05	0.000348	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.74e-05	0.000346	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.73e-05	0.000345	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	5.73e-05	0.000345	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.7e-05	0.000343	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.67e-05	0.000341	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	5.55e-05	0.000334	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.54e-05	0.000334	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.51e-05	0.000332	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.49e-05	0.000331	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.47e-05	0.00033	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.47e-05	0.000329	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	5.46e-05	0.000329	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	5.46e-05	0.000329	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	5.42e-05	0.000327	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.41e-05	0.000326	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.38e-05	0.000324	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.38e-05	0.000324	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.37e-05	0.000323	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	5.33e-05	0.000321	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.27e-05	0.000317	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	5.18e-05	0.000312	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	5.15e-05	0.00031	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.09e-05	0.000307	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.08e-05	0.000306	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.08e-05	0.000306	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.05e-05	0.000304	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	5.04e-05	0.000304	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5e-05	0.000301	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5e-05	0.000301	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.94e-05	0.000298	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.94e-05	0.000297	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.92e-05	0.000296	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.91e-05	0.000296	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.9e-05	0.000295	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.89e-05	0.000295	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.83e-05	0.000291	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.82e-05	0.00029	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.8e-05	0.000289	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.79e-05	0.000289	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.78e-05	0.000288	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	4.7e-05	0.000283	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.68e-05	0.000282	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.67e-05	0.000281	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	4.67e-05	0.000281	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	4.66e-05	0.000281	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.66e-05	0.000281	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.65e-05	0.00028	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.64e-05	0.000279	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	4.64e-05	0.000279	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.6e-05	0.000277	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.57e-05	0.000275	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.54e-05	0.000273	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.53e-05	0.000273	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.51e-05	0.000272	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.48e-05	0.00027	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.44e-05	0.000267	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.41e-05	0.000266	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	4.4e-05	0.000265	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.29e-05	0.000259	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.25e-05	0.000256	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.24e-05	0.000255	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.22e-05	0.000254	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.19e-05	0.000253	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.19e-05	0.000252	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.17e-05	0.000251	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.16e-05	0.000251	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.16e-05	0.00025	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	4.14e-05	0.000249	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.11e-05	0.000248	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	4.1e-05	0.000247	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.1e-05	0.000247	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.08e-05	0.000246	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.05e-05	0.000244	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.04e-05	0.000243	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.01e-05	0.000241	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.99e-05	0.00024	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	3.98e-05	0.00024	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.98e-05	0.00024	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.96e-05	0.000239	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.9e-05	0.000235	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.88e-05	0.000234	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.87e-05	0.000233	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.83e-05	0.000231	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.82e-05	0.00023	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.81e-05	0.00023	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.8e-05	0.000229	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.79e-05	0.000229	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.79e-05	0.000228	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.78e-05	0.000228	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	3.77e-05	0.000227	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.75e-05	0.000226	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.7e-05	0.000223	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.68e-05	0.000222	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.68e-05	0.000222	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.58e-05	0.000216	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.58e-05	0.000216	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	3.56e-05	0.000214	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.54e-05	0.000213	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.52e-05	0.000212	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	3.51e-05	0.000211	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	3.5e-05	0.00021	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.49e-05	0.00021	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.46e-05	0.000209	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.45e-05	0.000208	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.39e-05	0.000204	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.25e-05	0.000196	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.24e-05	0.000195	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.23e-05	0.000195	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.22e-05	0.000194	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.2e-05	0.000193	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.19e-05	0.000192	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.18e-05	0.000192	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.15e-05	0.00019	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.15e-05	0.00019	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.13e-05	0.000189	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.08e-05	0.000186	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	3.07e-05	0.000185	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.07e-05	0.000185	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.05e-05	0.000184	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	2.99e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.98e-05	0.00018	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.91e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.91e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	2.89e-05	0.000174	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	2.87e-05	0.000173	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	2.84e-05	0.000171	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.71e-05	0.000163	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.71e-05	0.000163	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.71e-05	0.000163	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.67e-05	0.000161	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.66e-05	0.00016	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.66e-05	0.00016	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.62e-05	0.000158	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.61e-05	0.000157	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.51e-05	0.000151	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.49e-05	0.00015	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.47e-05	0.000149	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	2.45e-05	0.000148	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	2.43e-05	0.000147	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	2.43e-05	0.000146	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.42e-05	0.000146	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.41e-05	0.000145	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.4e-05	0.000144	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.36e-05	0.000142	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.35e-05	0.000141	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	2.29e-05	0.000138	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.28e-05	0.000138	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.23e-05	0.000134	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	2.08e-05	0.000125	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.07e-05	0.000125	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.04e-05	0.000123	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.03e-05	0.000123	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.03e-05	0.000122	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2e-05	0.00012	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.99e-05	0.00012	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.95e-05	0.000117	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.94e-05	0.000117	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1.88e-05	0.000113	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.88e-05	0.000113	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.88e-05	0.000113	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.87e-05	0.000112	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.86e-05	0.000112	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.71e-05	0.000103	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.68e-05	0.000101	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.68e-05	0.000101	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.65e-05	9.91e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.6e-05	9.67e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	1.6e-05	9.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.53e-05	9.21e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.23e-05	7.42e-05	CbGpPWpGaD
